Company / R&D per Share
Senti Biosciences Holdings, Inc. R&D per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$7.11
FY2025
5-year range
$0.65 / $7.39
FY2022-FY2025
Trend
+1.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.65 to $7.11 over the past 2 years.
Based on SEC 10-K filings.
7.11 in FY2025 with a 3-year CAGR of -1.2%.
Improved from $0.65 to $7.11 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 1.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.11 | +1.1% |
| FY2024 | $7.04 | +984.0% |
| FY2023 | $0.65 | -91.2% |
| FY2022 | $7.39 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026